News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,949 Results
Type
Article (40816)
Company Profile (268)
Press Release (665865)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (205837)
Career Advice (2369)
Deals (35688)
Drug Delivery (95)
Drug Development (81738)
Employer Resources (174)
FDA (16339)
Job Trends (14955)
News (348399)
Policy (32996)
Tag
Academia (2616)
Accelerated approval (5)
Adcomms (20)
Allergies (88)
Alliances (49955)
ALS (89)
Alzheimer's disease (1395)
Antibody-drug conjugate (ADC) (125)
Approvals (16342)
Artificial intelligence (259)
Autoimmune disease (21)
Automation (16)
Bankruptcy (361)
Best Places to Work (11708)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (187)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (279)
Cancer (2271)
Cardiovascular disease (176)
Career advice (1946)
Career pathing (30)
CAR-T (152)
Cell therapy (425)
Cervical cancer (19)
Clinical research (66512)
Collaboration (842)
Company closure (1)
Compensation (547)
Complete response letters (19)
COVID-19 (2616)
CRISPR (40)
C-suite (243)
Cystic fibrosis (100)
Data (2228)
Decentralized trials (2)
Denatured (18)
Depression (45)
Diabetes (272)
Diagnostics (6471)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (87092)
Editorial (37)
Employer branding (21)
Employer resources (148)
Events (113801)
Executive appointments (726)
FDA (17613)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (21)
Gene therapy (309)
GLP-1 (716)
Government (4550)
Grass and pollen (5)
Guidances (68)
Healthcare (19104)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (118)
Indications (30)
Infectious disease (2760)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (399)
IPO (16645)
IRA (40)
Job creations (3662)
Job search strategy (1668)
Kidney cancer (10)
Labor market (38)
Layoffs (469)
Leadership (17)
Legal (7991)
Liver cancer (75)
Lung cancer (321)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (305)
MASH (70)
Medical device (13551)
Medtech (13556)
Mergers & acquisitions (19592)
Metabolic disorders (691)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1937)
NextGen: Class of 2025 (6616)
Non-profit (4529)
Now hiring (39)
Obesity (366)
Opinion (205)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (84)
Parkinson's disease (151)
Partnered (21)
Patents (234)
Patient recruitment (113)
Peanut (47)
People (57848)
Pharmaceutical (66)
Pharmacy benefit managers (18)
Phase I (20734)
Phase II (29309)
Phase III (21783)
Pipeline (1213)
Policy (139)
Postmarket research (2585)
Preclinical (8842)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (380)
Real estate (5957)
Recruiting (65)
Regulatory (22548)
Reports (46)
Research institute (2363)
Resumes & cover letters (408)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (132)
Series B (85)
Service/supplier (13)
Sickle cell disease (52)
Special edition (15)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3619)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (694)
Venture capitalists (41)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (37)
Last 7 days (859)
Last 30 days (2529)
Last 365 days (32890)
2025 (10873)
2024 (35497)
2023 (40436)
2022 (51587)
2021 (56153)
2020 (54533)
2019 (47171)
2018 (35494)
2017 (32562)
2016 (31900)
2015 (38005)
2014 (31704)
2013 (26756)
2012 (29001)
2011 (29766)
2010 (27698)
Location
Africa (765)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38403)
Australia (6378)
California (6170)
Canada (2024)
China (527)
Colorado (266)
Connecticut (275)
Delaware (148)
Europe (84335)
Florida (916)
Georgia (207)
Idaho (57)
Illinois (542)
India (26)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (901)
Massachusetts (4610)
Michigan (221)
Minnesota (394)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1737)
New Mexico (28)
New York (1767)
North Carolina (972)
North Dakota (9)
Northern California (2692)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1145)
South Carolina (23)
South Dakota (1)
Southern California (2318)
Tennessee (101)
Texas (910)
United States (23287)
Utah (183)
Virginia (151)
Washington D.C. (63)
Washington State (561)
West Virginia (3)
Wisconsin (55)
706,949 Results for "gel e inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
April 24, 2025
·
4 min read
Press Releases
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
April 10, 2025
·
7 min read
Press Releases
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
April 17, 2025
·
12 min read
Pharm Country
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.
May 29, 2024
·
3 min read
Press Releases
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections
April 23, 2025
·
5 min read
Press Releases
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
March 3, 2025
·
9 min read
Press Releases
SolasCure Enrols First Patient in a Next Phase II Clinical Trial to Advance Aurase Wound Gel
March 17, 2025
·
2 min read
Press Releases
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
February 14, 2025
·
10 min read
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to Progena
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”) to ProgenaCare Global LLC (“ProgenaCare”).
June 27, 2024
·
4 min read
Press Releases
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson’s Disease
February 6, 2025
·
6 min read
1 of 70,695
Next
